Pericardial effusion is an abnormal buildup of fluid in the thin, double-layered sac that surrounds the heart. A small amount of fluid normally sits in this space to reduce friction as the heart beats, but when disease, injury, or inflammation causes excess fluid to accumulate, the resulting pressure can interfere with how the heart fills and pumps. What makes pericardial effusion tricky is that the danger depends less on the total volume of fluid and more on how fast it accumulates, which means a modest effusion that develops suddenly can be far more threatening than a large one that collects slowly over weeks.
The Pericardial Space Under Normal Conditions
The pericardium is a fibrous sac made of two layers with a thin cavity between them. Under healthy conditions, this cavity holds roughly 15 to 50 milliliters of fluid, produced mainly by ultrafiltration of plasma across the pericardial membrane. The fluid serves as a lubricant during every heartbeat and is continuously drained by a network of lymphatic vessels and absorbed in part by the mesothelial cells that line the pericardium itself.1PubMed Central. Physiology of pericardial fluid production and drainage When something disrupts this balance, whether by increasing production, blocking drainage, or both, fluid accumulates and the sac stretches to accommodate it. If the buildup is gradual, the pericardium can stretch considerably and hold several hundred milliliters without immediately compressing the heart. If the buildup is rapid, even a relatively small volume can push inward on the cardiac chambers and compromise blood flow.
Why the Speed of Accumulation Matters More Than the Volume
This is the single most important concept for understanding pericardial effusion. The pericardium is somewhat elastic, but it adapts slowly. A chronic effusion that develops over weeks or months allows the sac to stretch gradually, which is why some patients walk around with large effusions and relatively mild symptoms. By contrast, an acute effusion that appears in hours, say from a chest wound or a ruptured heart wall, can cause life-threatening compression with far less fluid because the pericardium has had no time to accommodate it.2PubMed Central. Pericardial Effusion: Overview of Aetiology, Pathophysiology, Diagnosis, and Management This is why doctors focus heavily on how quickly symptoms are evolving rather than simply measuring the size of an effusion on imaging.
Common Causes
The causes of pericardial effusion vary depending on geography and the patient population. In high-income countries, the most common cause is idiopathic pericarditis, meaning inflammation of the pericardium without a clearly identified trigger, which is often presumed to be viral in origin. In lower-income regions, tuberculosis remains the leading culprit.3PubMed Central. Diagnosis and management of pericardial effusion Beyond those two broad categories, the list of potential causes is long:
- Cancer: Lung cancer, breast cancer, melanoma, and lymphoma are the tumors most likely to involve the pericardium, usually by spreading from a nearby site or through the bloodstream.4PubMed Central. Pericardial effusion in oncological patients: current knowledge and principles of management
- Autoimmune diseases: Conditions like systemic lupus erythematosus (lupus) can inflame the pericardium. In some cases, a pericardial effusion is the first sign that an autoimmune disease is present, appearing before more classic symptoms like joint pain or skin rashes.5PubMed Central. Pericardial Effusion as the Initial Presentation of Systemic Lupus Erythematosus in a 37-Year-Old Female
- Kidney failure: Impaired kidney function leads to a buildup of waste products in the blood that can irritate the pericardium.
- Hypothyroidism: Severely low thyroid function can cause fluid to accumulate gradually in the pericardial space.
- Cardiac injury: Heart attacks, heart surgery, and even catheter-based cardiac procedures can all damage the pericardium and trigger fluid accumulation. This delayed inflammatory response is known as post-cardiac injury syndrome, and it has become more common as interventional cardiology procedures have proliferated.6PubMed Central. Post-Cardiac Injury Syndrome: A Paradigm Shift in Diagnosis and Management
- Infections: Bacterial, viral, and fungal infections can all cause pericardial effusion, though the types that dominate depend on the population.
Post-Cardiac Injury Syndrome
Post-cardiac injury syndrome deserves its own mention because it catches many patients off guard. After a heart attack, open-heart surgery, or a catheter procedure, the immune system can mount a delayed inflammatory reaction targeting the pericardium. There is typically a latency period of weeks to months between the initial cardiac event and the appearance of the effusion, which is why patients sometimes develop symptoms well after they thought they were recovering normally.7PubMed Central. Post-cardiac injury syndrome: An evidence-based approach to diagnosis and treatment The underlying mechanism appears to be autoimmune: the initial damage to heart tissue releases proteins that the body’s immune system then mounts a reaction against. Researchers have found antibodies targeting heart-muscle proteins like actin and myosin in patients who develop this syndrome after surgery.8PubMed Central. Post-cardiac injury syndrome: An evidence-based approach to diagnosis and treatment Recognizing this pattern matters because the treatment is anti-inflammatory medication rather than additional cardiac procedures.
Symptoms and Warning Signs
Small pericardial effusions are often discovered incidentally on imaging done for unrelated reasons, and many produce no symptoms at all. As the effusion grows or accumulates quickly, people tend to notice chest pressure or discomfort, shortness of breath that worsens when lying flat, and sometimes a dry cough. The breathlessness often improves when sitting up and leaning forward, because that position shifts the fluid and takes some pressure off the heart.
When the effusion progresses toward cardiac tamponade, the situation becomes urgent. Classic warning signs include a rapid heartbeat, falling blood pressure, muffled heart sounds on examination, and distended neck veins. A hallmark finding is pulsus paradoxus, an exaggerated drop in blood pressure during each inhalation. This happens because the pressurized pericardium forces the heart’s chambers to compete for limited space. When you breathe in, the right side of the heart fills slightly more due to increased blood return from the body, but under pericardial constraint this expansion compresses the left side of the heart via the shared wall between the ventricles and through the pericardium itself, temporarily reducing the blood pumped to the rest of the body.9PubMed Central. Using a human cardiovascular-respiratory model to characterize cardiac tamponade and pulsus paradoxus
How Pericardial Effusion Is Diagnosed
Echocardiography, essentially an ultrasound of the heart, is the first-line tool. It is fast, widely available, does not involve radiation, and can be performed at the bedside. A structured echocardiographic approach looks at the quantity and quality of the fluid, whether any of the heart’s chambers are being compressed, how the heart’s filling patterns change with breathing, and whether the large vein returning blood to the heart (the inferior vena cava) is distended or collapsing normally.10PubMed Central. Echocardiographic Evaluation of Pericardial Effusion and Cardiac Tamponade Traditionally, effusions are graded by measuring the width of the fluid space: small, moderate, or large. However, this linear measurement correlates only modestly with the actual volume of fluid. Volumetric methods that estimate the three-dimensional shape of the fluid collection have shown stronger correlation with the volume ultimately drained.11Journal of the American College of Cardiology. Echocardiographic Assessment of Pericardial Effusion Size: Time for a Quantitative Approach
When echocardiography leaves questions unanswered, CT and cardiac MRI come into play. MRI is especially useful because it can characterize the type of fluid present, identify whether the pericardium itself is inflamed or thickened, and detect simultaneous inflammation in the heart muscle.12PubMed Central. Diagnosis, treatment, and management of pericardial effusion- review MRI also helps distinguish simple effusions from complex or loculated (walled-off) collections that may not drain easily.13PubMed. Cardiac MRI: Part 2, pericardial diseases For cases where the underlying cause remains unclear, it can provide the morphologic and functional information needed to guide treatment.
What Fluid Analysis Reveals
When a pericardial effusion is drained, either for treatment or to figure out what is causing it, the fluid itself gets sent to the lab. Normal pericardial fluid has high levels of protein and the enzyme lactate dehydrogenase but relatively low cholesterol and glucose levels, and it contains a substantial number of mesothelial cells.14PubMed. What is the normal composition of pericardial fluid? Comparing the fluid’s chemistry to these reference values can help narrow the cause, but the reality is that standard biochemistry has limited ability to distinguish between different types of effusions.
The most revealing lab test on pericardial fluid is cytology, the examination of the cells under a microscope. In patients with newly diagnosed cancers involving the pericardium, about seven in ten had positive cytology results, meaning cancer cells were found directly in the fluid. Overall, fluid analysis had a substantially higher diagnostic yield in patients whose effusions turned out to be cancer-related compared to those with other causes.15PubMed. Pericardial Fluid Analysis in Diagnosis and Prognosis of Patients Who Underwent Pericardiocentesis So when cancer is suspected, draining the fluid is not just therapeutic but also diagnostically valuable. For other causes, the fluid alone often cannot tell you what the problem is, and additional blood tests, imaging, and clinical context fill in the gaps.
Treatment Options
Treatment depends entirely on the cause, the size of the effusion, and whether the patient is hemodynamically stable, meaning the heart is still pumping effectively.
For small, stable effusions caused by viral or idiopathic pericarditis, anti-inflammatory medications are the backbone of treatment. Non-steroidal anti-inflammatory drugs like ibuprofen are first-line, frequently combined with colchicine, an old gout medication that has found new life in pericardial disease. Colchicine has been shown to help resolve even large pericardial effusions, sometimes within a week, when standard anti-inflammatory drugs alone have failed.16PubMed Central. Colchicine for large pericardial effusion Corticosteroids are used in some cases but are generally reserved for situations where other options have not worked, because they can increase the risk of recurrence.
For large effusions causing hemodynamic compromise, particularly tamponade, the fluid needs to be drained urgently. The standard approach is pericardiocentesis: a needle is inserted through the chest wall into the pericardial space, usually guided by echocardiography or fluoroscopy. This image-guided approach has dramatically improved the safety of the procedure, which was historically performed essentially blind and carried significant risk of complications.17Mayo Clinic Proceedings. Percutaneous Echocardiographically Guided Pericardiocentesis: Review of 152 Consecutive Cases When pericardiocentesis is not sufficient, particularly for effusions that keep returning, a surgical pericardial window can be created. This is a small opening in the pericardium that allows fluid to drain continuously into the chest cavity where it can be absorbed.
Pericardiocentesis Versus Surgical Window for Cancer-Related Effusions
For patients with cancer-related pericardial effusions, the choice between needle drainage and surgical window is a recurring debate. A meta-analysis of retrospective studies found that pericardiocentesis had a roughly threefold higher rate of procedure failure compared to surgical approaches. However, the surgical group had a higher rate of death, which may reflect the greater invasiveness of the operation in patients who are already sick from cancer.18PubMed Central. Pericardiocentesis vs. surgical pericardial window for first occurrence of malignancy-related pericardial effusion: a meta-analysis of retrospective studies Complication rates for bleeding, infection, and other adverse events were similar between the two approaches. In practice, the choice depends on the patient’s overall condition, life expectancy, and how likely the effusion is to recur.
A systematic review looking specifically at the types of cancer causing malignant pericardial effusions found that solid tumors of the lung, gastrointestinal tract, and kidney accounted for the majority, followed by primary cardiac tumors (most commonly angiosarcoma and pericardial mesothelioma) and blood cancers like leukemia and lymphoma.19CJC Open. Malignant Pericardial Effusion: A Systematic Review Identifying the specific cancer type matters because it affects prognosis and whether systemic treatment can prevent the effusion from coming back.
Immune Checkpoint Inhibitors and the Pericardium
A newer and increasingly recognized cause of pericardial effusion is immune checkpoint inhibitor therapy, a class of cancer drugs that works by releasing the brakes on the immune system so it can attack tumors. The downside is that the unleashed immune system sometimes attacks healthy tissues too, and the pericardium is one target. In one study, patients treated with checkpoint inhibitors had more than a fourfold increase in the risk of pericarditis or pericardial effusion compared to cancer patients not receiving these drugs.20PubMed Central. Pericardial disease in patients treated with immune checkpoint inhibitors The drugs most commonly implicated are nivolumab and pembrolizumab, and the condition appears most often in men with lung cancer, which may partly reflect the demographics of who receives these drugs most frequently.21PubMed Central. Immune checkpoint inhibitors and pericardial disease: a systematic review
Despite the increased risk, the likelihood of developing a pericardial effusion serious enough to require drainage remains low. In one large cohort, the prevalence of hemodynamically significant effusions requiring pericardiocentesis among patients on checkpoint inhibitors was under half a percent, and survival after drainage was similar regardless of whether the patient had been on these drugs or not.22PubMed. Targeted Cancer Therapies With Pericardial Effusions Requiring Pericardiocentesis Focusing on Immune Checkpoint Inhibitors The takeaway for patients on immunotherapy is awareness, not alarm: know the symptoms of pericardial effusion, but routine screening echocardiograms are generally not considered necessary.
Recurrent and Refractory Pericardial Disease
Some patients develop a frustrating cycle in which their pericarditis and effusion resolve with treatment, only to return weeks or months later. Recurrent pericarditis is thought to involve the interleukin-1 inflammatory pathway, and over the past two decades this understanding has opened the door to targeted therapies. Anakinra and rilonacept, both of which block the interleukin-1 pathway, have shown benefit in randomized clinical trials for patients whose disease keeps coming back despite colchicine and who are dependent on corticosteroids to control symptoms.23PubMed Central. Emerging Therapies for Recurrent Pericarditis: Interleukin-1 inhibitors Rilonacept was the first drug specifically approved by the FDA for recurrent pericarditis. These medications represent a meaningful advance for a subset of patients who previously had few good options beyond long-term steroid use, which carries its own substantial side effects.
Effusive-Constrictive Pericarditis
In some cases, pericardial effusion exists alongside a stiff, fibrotic pericardium that restricts the heart’s ability to fill properly. This combined condition, called effusive-constrictive pericarditis, is diagnosed when draining the fluid does not relieve the elevated pressures inside the heart. The classic hemodynamic finding is that right atrial pressure remains high even after the pericardial fluid has been completely removed.24PubMed Central. Contemporary Assessment and Management of Effusive-Constrictive Pericarditis In a landmark study, all patients presented with tamponade and had elevated pressures inside the pericardium. After pericardiocentesis, the pericardial pressure itself dropped to normal, but the pressures within the cardiac chambers remained elevated with a characteristic dip-and-plateau pattern, confirming that the problem was not just the fluid but also a thickened, constricting pericardium.25PubMed. Effusive-constrictive pericarditis
Effusive-constrictive pericarditis is more common in settings where tuberculosis drives pericardial disease, but it can arise from radiation therapy, prior cardiac surgery, or prolonged idiopathic pericarditis. The condition is characterized by fluid in the pericardial space and a rigid, fibrotic pericardium that together restrict the heart’s filling.26Cardiology in Review. A Comprehensive Review of Effusive-Constrictive Pericarditis, Diagnosis, and Management Some patients improve with aggressive anti-inflammatory treatment if the constriction is still in its inflammatory phase, but others ultimately need surgical removal of the pericardium, a major operation called pericardiectomy.
Pericardial Effusion in Children
The causes of pericardial effusion in children differ from adults. In a retrospective study from a pediatric referral center, renal failure and parapneumonic effusion (fluid associated with lung infections) were the leading causes. Viral and bacterial pericarditis ranked lower overall, but bacterial pericarditis was disproportionately represented among severe cases. Most children presented with acute symptoms, with breathing problems being the most common complaint. About four in five children were hemodynamically stable at presentation, and only a small fraction showed signs of tamponade.27PubMed Central. Pericardial effusion among children: Retrospective analysis of the etiology and short‐term outcome in a referral center in the south of Iran
Another pediatric study found a different distribution, with cancer being the most common underlying condition, followed by idiopathic causes. This likely reflects the referral patterns of a tertiary medical center where children with complex illnesses concentrate. Recurrence was common among children who underwent drainage, with roughly six in ten developing repeat effusions, and about four in ten of those required drainage again. Encouragingly, the vast majority of effusions, whether drained or managed conservatively, resolved within three months.28PubMed. Etiology, management, and outcome of pediatric pericardial effusions The variation between these two studies highlights how much the cause profile depends on the patient population a center serves.
Pericarditis and Hidden Cancer
One finding that has emerged from population-level research is that acute pericarditis itself may be a signal of an undetected cancer. A large Danish study of nearly 14,000 patients hospitalized with acute pericarditis found that the subsequent rate of cancer diagnosis was about 50 percent higher than expected in the general population. The excess risk was driven mainly by lung, kidney, and bladder cancer, as well as lymphoma and leukemia.29PubMed Central. Pericarditis as a Marker of Occult Cancer and a Prognostic Factor for Cancer Mortality This does not mean that everyone diagnosed with pericarditis should worry about cancer; the absolute numbers remain modest. But it does suggest that when pericarditis occurs without an obvious explanation, especially in older adults or those with risk factors, some clinicians may consider age-appropriate cancer screening as part of the workup.